| A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment. (NCT04239014) | AstraZeneca | 2020-08-07 |
| Cabozantinib to Treat Recurrent Liver Cancer Post Transplant (NCT04204850) | University Health Network, Toronto | 2020-08-07 |
| Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients (NCT04494204) | PUNEET MITTAL | 2020-08-07 |
| Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma (NCT04402138) | SCRI Development Innovations, LLC | 2020-08-07 |
| IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer (NCT04434482) | Impact Therapeutics, Inc. | 2020-08-07 |
| Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma (NCT04277845) | Samsung Medical Center | 2020-08-06 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types (NCT04300556) | Eisai Inc. | 2020-08-06 |
| Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet (NCT04191616) | Amgen | 2020-08-06 |
| Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 (NCT04414631) | University Hospital, Basel, Switzerland | 2020-08-06 |
| Belatacept in De Novo Heart Transplantation (NCT04477629) | NYU Langone Health | 2020-08-06 |
| Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) (NCT04428151) | Merck Sharp & Dohme LLC | 2020-08-06 |
| Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors (NCT04079712) | National Cancer Institute (NCI) | 2020-08-06 |
| Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE) (NCT04402385) | Yale University | 2020-08-06 |
| Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally (NCT04027036) | Instituto Nacional de Saúde, Mozambique | 2020-08-06 |
| Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax (NCT04501939) | University of California, San Diego | 2020-08-06 |
| Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder. (NCT04082806) | Erich Seifritz | 2020-08-06 |
| A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma (NCT04356729) | F. Stephen Hodi, MD | 2020-08-06 |
| Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (NCT04430192) | Peter MacCallum Cancer Centre, Australia | 2020-08-06 |
| A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor (NCT04412564) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-08-05 |
| Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma (NCT04417530) | Aura Biosciences | 2020-08-05 |
| Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 (NCT04550325) | Kamada, Ltd. | 2020-08-05 |
| Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular Disorder (NCT06231212) | Chulalongkorn University | 2020-08-05 |
| Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung Cancer (NCT04111705) | Intergroupe Francophone de Cancerologie Thoracique | 2020-08-05 |
| Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY (NCT04241601) | Cambridge University Hospitals NHS Foundation Trust | 2020-08-05 |
| Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (NCT04563533) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2020-08-05 |
| Dexmedetomidine Compared to Ondansetron for Postanaesthetic Shivering in Patients Undergoing a Cesarean Section (NCT06289335) | Hospital Central "Dr. Ignacio Morones Prieto" | 2020-08-05 |
| 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings (NCT04504110) | Peking Union Medical College Hospital | 2020-08-05 |
| Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease (NCT04382924) | Algernon Pharmaceuticals | 2020-08-05 |
| Futibatinib in Patients With Specific FGFR Aberrations (NCT04189445) | Taiho Oncology, Inc. | 2020-08-05 |
| Open-label Extension of the HOPE-2 Trial (NCT04428476) | Capricor Inc. | 2020-08-05 |
| Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia. (NCT04425655) | University of California, San Diego | 2020-08-05 |
| Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19 (NCT05501418) | Ever Supreme Bio Technology Co., Ltd. | 2020-08-05 |
| Saracatinib Trial TO Prevent FOP (NCT04307953) | Amsterdam UMC, location VUmc | 2020-08-05 |
| A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients (NCT04294472) | Vera Therapeutics, Inc. | 2020-08-05 |
| Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer (NCT04560686) | M.D. Anderson Cancer Center | 2020-08-05 |
| Use of Angiotensin-(1-7) in COVID-19 (NCT04633772) | Erasme University Hospital | 2020-08-05 |
| A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) (NCT04364763) | Renibus Therapeutics, Inc. | 2020-08-05 |
| PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC) (NCT04504383) | Protagonist Therapeutics, Inc. | 2020-08-05 |
| Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones (NCT04090398) | National Cancer Institute (NCI) | 2020-08-04 |
| Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation (NCT03953898) | National Cancer Institute (NCI) | 2020-08-04 |
| Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities (NCT04572893) | Bristol-Myers Squibb | 2020-08-04 |
| A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery (NCT03943446) | Takeda | 2020-08-04 |
| A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC. (NCT04495179) | AstraZeneca | 2020-08-04 |
| Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer (NCT04221165) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2020-08-04 |
| Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis (NCT04532710) | Marinomed Biotech AG | 2020-08-04 |
| A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis (NCT04713072) | ACELYRIN Inc. | 2020-08-04 |
| Vosoritide for Selected Genetic Causes of Short Stature (NCT04219007) | Andrew Dauber | 2020-08-04 |
| Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects (NCT04480957) | Arcturus Therapeutics, Inc. | 2020-08-04 |
| Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement (NCT04062695) | Charite University, Berlin, Germany | 2020-08-04 |
| A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients (NCT04412707) | Oncopeptides AB | 2020-08-04 |
| Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents (NCT03923257) | Sue O'Dorisio | 2020-08-04 |
| A Study of Niraparib in Patients With Relapsed Ovarian Cancer (NCT04392102) | Zai Lab (Shanghai) Co., Ltd. | 2020-08-04 |
| The Açaí Berry COVID-19 Anti-Inflammation Trial (NCT04404218) | University Health Network, Toronto | 2020-08-04 |
| A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors (NCT04481009) | Eucure (Beijing) Biopharma Co., Ltd | 2020-08-04 |
| Safety of Maraviroc for Post-stroke Depression (NCT05932550) | Tel-Aviv Sourasky Medical Center | 2020-08-04 |
| The Value of Sintilimab Consolidation Therapy After Definitive Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer (NCT04212598) | Wuhan University | 2020-08-03 |
| Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction (NCT04446897) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-08-03 |
| A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC (NCT04501523) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2020-08-03 |
| Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV (NCT04353778) | Icahn School of Medicine at Mount Sinai | 2020-08-03 |
| Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) (NCT04509700) | Incyte Corporation | 2020-08-03 |
| Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis (NCT04314661) | PT. Prodia Stem Cell Indonesia | 2020-08-03 |
| Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine (NCT04192370) | Brigham and Women's Hospital | 2020-08-03 |
| Genentech Xenon MRI Idiopathic Pulmonary Fibrosis (NCT04071769) | Duke University | 2020-08-03 |
| COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation (NCT04476953) | Mayo Clinic | 2020-08-03 |
| Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee (NCT05737173) | Queen Savang Vadhana Memorial Hospital, Thailand | 2020-08-03 |
| Dapagliflozin Effect in Cognitive Impairment in Stroke Trial (NCT05565976) | Jaime Daniel Mondragon | 2020-08-01 |
| Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients (NCT04501354) | Ahmad Jabir Rahyussalim | 2020-08-01 |
| TXA in Spinal Fusion (NCT04272606) | Catherine R. Olinger | 2020-08-01 |
| Sintilimab and Lenalidomide as a Treatment for CAEBV (NCT04518982) | Zhao Wang | 2020-08-01 |
| High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery (NCT04520568) | Alexandria University | 2020-08-01 |
| Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen (NCT04502069) | RedHill Biopharma Limited | 2020-08-01 |
| Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects (NCT04510402) | Brigham and Women's Hospital | 2020-08-01 |
| Combinatorial Therapy to Induce an HIV Remission (NCT04357821) | University of California, San Francisco | 2020-08-01 |
| Pembrolizumab, Ibrutinib and Rituximab in PCNSL (NCT04421560) | Dana-Farber Cancer Institute | 2020-08-01 |
| PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery (NCT04295317) | Shanghai Zhongshan Hospital | 2020-08-01 |
| Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC (NCT04541251) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2020-08-01 |
| Sofosbuvir in Treatment of COVID 19 (NCT04460443) | Tanta University | 2020-08-01 |
| Do Endotypes Predict Response and Sequelae in OSA Patients (NCT04875364) | University of California, San Diego | 2020-08-01 |
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors (NCT04106492) | Shasqi, Inc. | 2020-08-01 |
| Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 (NCT04607928) | Institut d'Investigació Biomèdica de Bellvitge | 2020-08-01 |
| A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (NCT04470141) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2020-08-01 |
| Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis (NCT04480632) | Fundación Cardiovascular de Colombia | 2020-08-01 |
| Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer (NCT04984980) | Fudan University | 2020-08-01 |
| ALPPS Combined With Tislelizumab in Liver Malignancy (NCT04996446) | Fudan University | 2020-08-01 |
| Abatacept for Patients With COVID-19 and Respiratory Distress (NCT04477642) | Beth Israel Deaconess Medical Center | 2020-08-01 |
| AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer (NCT04499118) | Sichuan Provincial People's Hospital | 2020-08-01 |
| A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 (NCT04363372) | 4D pharma plc | 2020-08-01 |
| A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma (NCT03786419) | Health Pharma Professional Research | 2020-08-01 |
| A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma (NCT04539444) | The First Affiliated Hospital of Soochow University | 2020-08-01 |
| The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma. (NCT04514081) | Chinese PLA General Hospital | 2020-08-01 |
| Phase 2 Study of NX9 for Delineation of Bowel Anatomy (NCT04789200) | Nextrast, Inc. | 2020-08-01 |
| Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery (NCT04275661) | Assiut University | 2020-08-01 |
| The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial (NCT04613102) | Elena Pope | 2020-08-01 |
| Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab (NCT04306965) | Tufts Medical Center | 2020-08-01 |
| Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance (NCT04332367) | Abramson Cancer Center at Penn Medicine | 2020-08-01 |
| Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells (NCT04426643) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-08-01 |
| SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias (NCT03801889) | Abfero Pharmaceuticals, Inc | 2020-08-01 |
| Administration of Chlorpromazine as a Treatment for COVID-19 (NCT04354805) | Cairo University | 2020-08-01 |
| Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke (NCT03045055) | Capital Medical University | 2020-08-01 |
| A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis (NCT04303195) | Neurogastrx, Inc. | 2020-08-01 |